Combination therapy for visceral leishmaniasis
نویسندگان
چکیده
منابع مشابه
Combination therapy for visceral leishmaniasis.
Combination therapy for the treatment of visceral leishmaniasis has increasingly been advocated as a way to increase treatment efficacy and tolerance, reduce treatment duration and cost, and limit the emergence of drug resistance. We reviewed the evidence and potential for combination therapy, and the criteria for the choice of drugs in such regimens. The first phase 2 results of combination re...
متن کاملCombination therapy with indolylquinoline derivative and sodium antimony gluconate cures established visceral leishmaniasis in hamsters.
2-(2"-Dichloroacetamidobenzyl)-3-(3'-indolylquinoline), designated indolylquinoline derivative A, reduced the splenic and the liver parasite burdens by >93.0% in Leishmania donovani-infected hamsters, whereas sodium antimony gluconate (SAG) reduced the burdens approximately 80.0%. Complete clearance of parasitemia from the livers and spleens was noticed when infected animals received indolylqui...
متن کاملCombined Immune Therapy for the Treatment of Visceral Leishmaniasis
Chronic disease caused by infections, cancer or autoimmunity can result in profound immune suppression. Immunoregulatory networks are established to prevent tissue damage caused by inflammation. Although these immune checkpoints preserve tissue function, they allow pathogens and tumors to persist, and even expand. Immune checkpoint blockade has recently been successfully employed to treat cance...
متن کاملCombination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.
Visceral leishmaniasis (VL) caused by the parasite Leishmania donovani is a potentially fatal disease. Available limited drugs are toxic, require prolonged treatment duration, and are costly. A low-cost parenteral formulation of paromomycin sulfate (PM) has recently been approved for the treatment of VL. Monotherapy with PM runs the risk of development of resistance. Hence, efforts are needed t...
متن کاملVisceral leishmaniasis.
While fully agreeing with Mr Cudmore that orchidopexy at 2 years of age is a difficult procedure and that the majority of orchidopexies are carried out by general surgeons or, unfortunately, delegated to a junior member of the team, the clinical and experimental evidence supporting orchidopexy at around the age of 2 years is overwhelming. The optimal age for orchidopexy cited in the annotation ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Infection and Microbiology
سال: 2013
ISSN: 2091-2145
DOI: 10.3126/ijim.v2i2.8318